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Abstract
Escherichia coli clonal group A (CgA) causes disease in humans. This is the first study investigating the prevalence of CgA among E. coli
from non-urine, extraintestinal infections in a northern European country. E. coli blood (n = 196) and paired urine (n = 195) isolates
from the same patients with bacteraemia of urinary tract origin were analysed. The isolates were collected from January 2003 through
May 2005 at four hospitals in Copenhagen, Denmark. Pulsed-field gel electrophoresis (PFGE) patterns, antimicrobial resistance and
patient characteristics were determined for all CgA isolates; presence of virulence-associated genes (VAGs) and serotypes were deter-
mined for the blood CgA isolates. Thirty blood isolates (15%) belonged to CgA. CgA blood isolates were associated with female
patients and sulfamethoxazole-trimethoprim resistance and they harboured a distinctive VAG profile. The blood and urine isolates from
each pair were found to be related in 26 of 27 CgA blood/urine pairs, confirming a urinary tract origin of infection. Furthermore, a rela-
tionship between the PFGE patterns of CgA blood/urine isolates and CgA isolates from UTI patients in general practice and a CgA iso-
late from a community-dwelling human reported previously, was found, suggesting a community origin of CgA. The finding of CgA
strains in 15% of the E. coli bloodstream infections with a urinary tract origin in Denmark suggests that CgA constitutes an important
clonal lineage among extraintestinal pathogenic E. coli. A reservoir of this pathogenic E. coli group in the community causing not only
UTI but also more severe infections such as bacteraemia has implications for public health.
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Introduction
Evidence is increasing that Escherichia coli causing urinary tract
infections (UTIs) and other extraintestinal infections may be
responsible for community epidemics [1,2]. A multidrug-
resistant clonal group, termed clonal group A (CgA), was iden-
tified as a cause of community-acquired UTI outbreaks in
North America in 2001 [3,4]. CgA isolates belong to E. coli
phylogenetic group D [5] and multilocus sequence typing
(MLST) clonal complex 69 (CC69) [6,7], they possess a con-
served virulence gene profile [3–5,8], and they are often resis-
tant to trimethoprim-sulphonamides [5,6].
CgA has a worldwide endemic distribution with a concen-
tration in the western world [9]. However, the distribution
of CgA in Europe has received little investigation [8–11].
CgA isolates cause extraintestinal infections and especially its
distribution among uropathogenic E. coli (UPEC) has been
investigated [5,6,8,10,12]. Thus, assessment of the distribu-
tion of CgA isolates in Europe and especially its prevalence
among complicated, extraintestinal infections such as blood-
stream infections is limited.
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The aim of the study was to investigate the prevalence of
CgA among E. coli isolates from cases of bacteraemia with a
urinary tract origin in a Northern European country. Also,
the study of paired blood and urine isolates from the same
patients could provide further insight into the pathogenesis
of E. coli bacteraemia with a urinary tract origin.
Methods
Bacterial isolates and patients
E. coli blood (n = 196) and urine (n = 195) isolates collected
from January 2003 through May 2005 from 195 adult
patients with both bacteraemia and bacteriuria admitted to
four hospitals in Copenhagen, as reported elsewhere [13],
were studied. From one patient, two E. coli blood isolates
were cultured. Epidemiological, clinical and laboratory data
for each infection episode were extracted from the patients’
medical records and the hospital administrative database.
Bacteraemia episodes were considered to be community
acquired when they were diagnosed within the first 48 h of
hospitalization and were considered hospital acquired after
this period. Sampling of the isolates was approved by the Sci-
entific Ethics Committee for the Capital Region of Denmark
[(KF) 01 2006-6371] [13].
Phylogenetic analysis
The phylogenetic background (A, B1, B2 and D) of the blood
isolates [13] and the corresponding urine isolates was deter-
mined by triplex PCR [14]. Classification of the isolates into
the four major E. coli phylogenetic lineages or non-typeable
(NT) isolates was undertaken according to Gordon et al.
[15].
Clonal group A
The phylogenetic group D isolates were screened by PCR
for CgA-associated single-nucleotide polymorphisms (SNPs)
in fumC and gyrB [12]. The presence of these SNPs identified
strains belonging to CC69 and excluded strains belonging to
the closely related CC394.
Virulence genotyping
The blood isolates were previously screened for the pres-
ence of 29 VAGs with known or suspected relevance to
ExPEC pathogenesis [13].
Antimicrobial resistance
Minimum inhibitory concentrations (MICs) of ciprofloxacin,
nalidixic acid, sulfamethoxazole and trimethoprim for the
blood isolates and the corresponding urine isolates were
determined by a micro broth dilution method as described
in Skjøt-Rasmussen et al., 2012 [13].
Pulsed-field gel electrophoresis
The CgA blood and urine isolates and the CgA reference
strain ATCC BAA-457 were typed by pulsed-field gel elec-
trophoresis (PFGE) with XbaI using the protocol made avail-
able by the CDC’s PulseNet database [16,17]. The PFGE
patterns were compared using BioNumerics 6.6 (Applied
Maths, Kortrijk, Belgium). Isolates were considered to be
related if their Dice similarity index was ‡85%. Also included
in the analysis was E. coli from animals (Danish broiler chick-
ens, n = 5), meat (Danish broiler chicken meat, n = 4) and
humans (Danish community-dwelling humans, n = 5; UTI
patients from general practice, n = 11) that were PFGE typed
as described earlier by Jakobsen et al. [10].
Serotyping
O, K and H antigens of the CgA blood isolates were
detected using standard methods [18].
Statistical analysis
Comparisons of proportions were based on the chi-square
test or, when expected numbers were <5, Fisher’s exact test
(two-tailed). In order to reduce the risk of type-1 error with
multiple comparisons, a p-value <0.01 was considered statis-
tically significant.
Results
Among the 196 blood and 195 urine isolates, 44 phylogroup
D blood isolates and 42 phylogroup D urine isolates were
found. Of the investigated phylogroup D isolates, 30 blood
isolates and 28 urine isolates belonged to CgA. Of these, 27
blood and urine CgA isolates, respectively, came from the
same 27 patients. Thus, CgA was found to be responsible
for 15% (30/196) of the bloodstream infections.
The median age of the 30 patients experiencing CgA bacter-
aemia was 78 years (range, 24–94 years). Of the CgA blood
isolates, 97% were from women whereas only 63% of the non-
CgA blood isolates were from women (p <0.001) (Table 1).
Among the 196 blood isolates, 21 isolates were from hos-
pital-acquired infections and 175 isolates were from commu-
nity-acquired infections. CgA was responsible for 17% (29/
175) of the community-acquired and 5% (1/21) of the hospi-
tal-acquired bloodstream infections with a urinary tract ori-
gin (Table 1).
Total 30-day mortality did not differ among the CgA bac-
teraemia episodes and the non-CgA episodes (Table 1).
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Sulphonamide-trimethoprim-resistant blood isolates repre-
sented 50% (15/30) of the CgA isolates as compared with
only 12% (20/166) of the non-CgA blood isolates (p <0.001)
(Table 1). Of the total 196 blood isolates, 40 were resistant
to both sulfamethoxazole and trimethoprim. Thus, the CgA
isolates accounted for 38% (15/40) of the sulfamethoxazole-
trimethoprim-resistant isolates from Danish patients with
bacteraemia of urinary tract origin. Fluoroquinolone resis-
tance was observed in only one of the 30 (3%) CgA blood
isolates (Table 1).
The CgA isolates were characterized by a distinctive profile
of VAGs different from non-CgA isolates that included iha, iutA
and sat, and lacked focG, sfa/focDE, agn43a (CFT073), agn43b
(CFT073), ireA, iroN, iss, cnf1, hlyD, malX and usp (Table 2).
Among the CgA isolates, 27 blood and 27 urine isolates
were paired, i.e. they came from the same patients; of these,
26 blood/urine pairs (96%) had related PFGE patterns
(Fig. 1).
We compared the PFGE patterns of CgA isolates of ani-
mal origin (Danish broiler chickens and Danish broiler
chicken meat) [14] with the 54 CgA blood and urine isolates,
but we did not find any relationship between the E. coli of
animal and human origin (data not shown). Furthermore, we
compared the PFGE patterns of the 54 CgA blood and urine
isolates with the PFGE patterns of CgA isolates from Danish
community-dwelling humans and UTI patients from general
practice [14]. Six of the CgA blood/urine pairs had PFGE
patterns related to those of six UTI patients from general
practice, and two of the blood/urine pairs had PFGE patterns
related to that of one isolate from a community-dwelling
human (data not shown) [14].
Serotypes of the CgA blood isolates belonging to blood/
urine pairs are shown in Fig. 1. Overall, eight different O
groups, six different K antigens and 20 different O:K:H sero-
types were detected (Fig. 1). Apart from the previously
described CgA O groups (O11, O15, O17, O44, O73, O77
and O86) [7,8,19,20], we found one O group not previously
associated with CgA, namely O125ab (n = 2). However, all
motile strains except one, O11:K52:H4, were H18, including
the three CgA blood isolates not belonging to a blood/urine
pair, which were: O rough:K52:H18, 125ab:K52:H18 and
O15:K52:H-.
Discussion
This study shows that the E. coli CgA can cause bacteraemia
with a urinary tract origin with a high prevalence (15%)
in Northern Europe. To our knowledge, only two
TABLE 1. Characteristics of E. coli blood clonal group A (CgA)
isolates (n = 30) compared with non-CgA isolates (n = 166)
from patients with bacteraemia of urinary tract origin
Category, trait








Community-acquired 29 (97) 146 (88) –
Hospital-acquired 1 (3) 20 (12)
30-day mortality
Yes 1 (3) 22 (13) –
No 29 (97) 144 (87)
Sex
Female 29 (97) 105 (63) <0.001
Male 1 (3) 61 (37)
Antimicrobial resistance profile
None 6 (20) 108 (65) <0.001
SUL 8 (27) 25 (15) –
TRI 0 (0) 1 (<1) –
SUL, TRI 15 (50) 20 (12) <0.001
CIP, NAL 0 (0) 4 (2) –
SUL, CIP, NAL 1 (3) 3 (2) –
SUL, TRI, CIP, NAL 0 (0) 5 (3) –
SUL, sulfamethoxazole; TRI, trimethoprim; CIP, ciprofloxacin; NAL, nalidixic
acid.
TABLE 2. Virulence-associated genes of E. coli blood clonal
group A (CgA) isolates (n = 30) compared with non-CgA
isolates (n = 166) from patients with bacteraemia of urinary
tract origin
Category, trait
Occurrence of trait, no. (%) of
isolates
pCgA (n = 30) Non-CgA (n = 166)
Adhesins
afa/draBC 0 (0) 5 (3) –
bmaE 1 (3) 5 (3) –
fimH 30 (100) 163 (98) –
focG 0 (0) 44 (27) 0.003
gafD 0 (0) 2 (1) –
iha 28 (93) 70 (42) <0.001
papAH 27 (90) 113 (68) –
sfa/focDE 0 (0) 66 (40) <0.001
Biofilm related
agn43 30 (100) 147 (89) –
agn43a (CFT073) 1 (3) 67 (40) <0.001
agn43b (CFT073) 0 (0) 57 (34) <0.001
agn43 (K12) 8 (27) 51 (31) –
Iron uptake
chuA 30 (100) 145 (87) –
fyuA 25 (83) 155 (93) –
ireA 0 (0) 65 (39) <0.001
iroN 0 (0) 110 (66) <0.001
iutA 29 (97) 118 (71) 0.006
Protectins
iss 1 (3) 45 (27) 0.009
kpsM II 25 (83) 138 (83) –
kpsM II K2 25 (83) 144 (87) –
kpsMT III 1 (3) 0 (0) –
traT 27 (90) 107 (64) –
Toxins
cdtB 0 (0) 18 (11) –
cnf1 0 (0) 56 (34) <0.001
hlyD 0 (0) 66 (40) <0.001
sat 26 (87) 62 (37) <0.001
Miscellaneous
ibeA 0 (0) 23 (14) –
malX 0 (0) 128 (77) <0.001
usp 0 (0) 133 (80) <0.001
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studies have investigated CgA in Northern Europe; both
studied UTI isolates [10,11]. Thus, our study is the first to
describe CgA among E. coli from bloodstream infections in
Northern Europe. The same percentage (15%) of CgA causing
community-acquired bloodstream infections was found in a
study based on strains collected during 2001–2003 in the Uni-
ted States; this study was also based on bloodstream infections
especially associated with preceding UTI [20].
FIG. 1. Pulsed-field gel electrophoresis of XbaI digested DNA from paired E. coli CgA blood (n = 27) and urine (n = 27) isolates. Isolate designa-
tion (ID) of all isolates (B: blood; U: urine) and serotypes of the blood isolates are shown on the right. The paired blood and urine isolates from
patient no. 122 were the only paired isolates not having related PFGE patterns.
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We found CgA to be significantly associated with women;
an explanation for this could be the origin of the studied
bacteraemia cases being the urinary tract because UTI among
adults is most common among females [21].
As in other studies [3–5,9,22], we identified a strong
association of CgA with sulphonamide-trimethoprim
resistance. We found CgA to account for 38% of the sulfa-
methoxazole-trimethoprim-resistant isolates from Danish
patients with bacteraemia of urinary tract origin. This is con-
sistent with studies conducted on UTI isolates; several stud-
ies have found CgA to account for up to 50% of
sulfamethoxazole-trimethoprim-resistant E. coli from women
with UTI [3,4]. For many years, sulfamethizole has been one
of the drugs of choice for treatment of uncomplicated UTI
in Denmark. Despite a reduction in the use of sulfonamides
in humans, sulphonamide resistance has remained relatively
constant during the last years (around 35–40%) [23]. The
use of trimethoprim, also used for treatment of UTI, has
increased over the last years [23], as has the level of tri-
methoprim resistance (around 34%) [24]. Despite neither
sulphonamides nor trimethoprim are being used for treat-
ment of bloodstream infections, we detected sulfamethoxazole-
trimethoprim-resistant CgA bloodstream isolates. Thus, the
presence of CgA could possibly explain the persistence of
resistance despite a decrease in antimicrobial consumption
[23].
To our knowledge, this is the first study to investigate the
association between the presence of CgA and outcome of
infection. We did not find a significant association between
CgA and 30-day mortality (Table 1). A reason for this might
be that our study included too few isolates needed for
evaluation of this factor. Like other studies, we also found
CgA isolates to be associated with a distinctive set of VAGs
[3–5,8]. Thus, our results indicate that despite exhibiting ex-
traintestinal virulence and antimicrobial resistance, CgA iso-
lates are not responsible for higher mortality as compared
with non-CgA isolates from bloodstream infections. The
higher mortality among non-CgA clonal isolates may be related
to the significantly higher frequency of the other VAGs pres-
ent (Table 2).
A strength of our study is the investigation of paired
blood and urine isolates from the same patients with bacter-
aemia of urinary tract origin; furthermore, to our knowledge
this is the first study to investigate such paired isolates
belonging to CgA. PFGE typing of the paired CgA blood and
urine isolates showed that 96% of the blood/urine pairs had
related PFGE patterns. This indicates that the assumption of
a urinary tract origin of the bloodstream infection is justified
when patients having concurrent bacteraemia and bacteriuria
are encountered.
We found PFGE relatedness between CgA blood/urine
pairs and UTI isolates from patients from general practice
and between blood/urine pairs and one isolate from a com-
munity-dwelling human. The finding of PFGE relatedness
between blood/urine isolates and the isolate from a commu-
nity-dwelling human (isolate 2171C04) is further substanti-
ated by the ability of 2171C04 to cause infection in the
murine model of human UTI [10]. The finding of a relation-
ship between Danish CgA isolates from patients with both
bacteraemia and bacteriuria collected during 2003–2005, UTI
patients from general practice collected during 2005–2006,
and community-dwelling humans collected in 2004 suggests a
common community origin of CgA. As CgA isolates have
previously been detected among isolates from broiler chick-
ens and broiler chicken meat in Denmark, food animals and
food may be a common source [10].
In this study, we found CgA with a high prevalence (15%)
among cases of bacteraemia with a urinary tract origin in a
Northern European country. This suggests that CgA consti-
tutes an important clonal lineage among ExPEC and repre-
sents an important public health threat. A reservoir of this
pathogenic E. coli group in the community causing not only
UTI but also more severe infections such as bacteraemia has
implications for public health.
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